Skip to main content
Watch Insiders

Corporate insider profile

Scott L Burrows Insider Trades

Latest reported as Chief Financial Officer of Spyre Therapeutics, Inc. (SYRE).

Purchase filings
0
Reported companies
1
Net open-market value
-$8,652,523.00
Latest transaction
Oct 1, 2026

Affiliated corporations

Reported company relationships

SYRELatest reported

Spyre Therapeutics, Inc.

Chief Financial Officer

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Oct 1, 2026Spyre Therapeutics, Inc. (SYRE)Chief Financial OfficerSale25,000$90.47$2,261,830
Sep 2, 2026Spyre Therapeutics, Inc. (SYRE)Chief Financial OfficerSale25,732$88.75$2,283,821
Aug 3, 2026Spyre Therapeutics, Inc. (SYRE)Chief Financial OfficerSale7,500$95.57$716,771
Jul 1, 2026Spyre Therapeutics, Inc. (SYRE)Chief Financial OfficerSale7,500$87.74$658,040
Jun 25, 2026Spyre Therapeutics, Inc. (SYRE)Chief Financial OfficerSale15,000$87.13$1,307,000
Jun 1, 2026Spyre Therapeutics, Inc. (SYRE)Chief Financial OfficerSale7,500$71.06$532,937
May 1, 2026Spyre Therapeutics, Inc. (SYRE)Chief Financial OfficerSale12,500$71.37$892,125